A vs BMY
Agilent Technologies vs Bristol Myers Squibb — AI-powered side-by-side comparison
| Metric | A | BMY |
|---|---|---|
| AI Score | 60 | 57 |
| Price | $136.08 | $60.52 |
| P/E Ratio | 27.27× | 17.00× |
| ROE | 0.2% | 0.4% |
| Revenue Growth YoY | — | — |
| Gross Margin | 0.5% | 0.7% |
| Debt / Equity | 0.47× | 2.22× |
| Dividend Yield | 0.0% | 0.0% |
| RSI (14) | 60.7 | 57.1 |
| Beta | 1.255 | 0.235 |
| Expected Upside | +1.6% | +2.6% |
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
A Full Analysis
BMY Full Analysis